Is a complete ABCL research report available?

No complete published report is available for AbCellera Biologics Inc. (ABCL) on this page. Market-directory data, when present, is not a substitute for a reviewed stock analysis.

AbCellera Biologics Inc. (ABCL)

NASDAQ: ABCL · USD

$5.31

-0.36 (-6.3%)· Recorded snapshot

Coverage state: Market snapshot only — no published research

Market snapshot recorded 2026-07-25 02:00 UTC. No published research is attached to this ticker. Prices and fundamentals on this server-rendered page are dated snapshots, not a real-time trading feed.

On-demand research

Generate the first ABCL analysis

Start the full research workflow when this ticker is ready in our data system.

Market cap	1.6B
Revenue (ttm)	79.2M
Net income (ttm)	-144M
EPS (ttm)	-$0.48
Shares out	305.4M
Volume	6,271,189
Beta	1.15
Price target	$10.5	+97.7%

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 79.2M
Net income (ttm): -144M
EPS (ttm): -$0.48
Market cap: 1.6B

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
ALNY	Alnylam Pharmaceuticals, Inc.	38.3B	72.6x	8.9x	78.4%	+49.7%	-11.8%	Strong Buy
ARGX	argenx SE	55.2B	32.2x	10.4x	50.6%	+58.8%	+48.3%	Strong Buy
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Hold

All ABCL indicators

Market & fundamental data

Available fields

215

Groups with data

Currency

USD

Showing 215 of 215 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001703057
Company name	AbCellera Biologics Inc.
Country	Canada
Country code	US
Cusip	00288U106
Employees	562
Employees Change	-34%
Employees Change Percent	-5.7
Enterprise value	$1.3B
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Biotechnology
IPO Date	2020-12-11
Isin	CA00288U1066
Last refreshed	2026-07-25
Market cap	$1.6B
Market cap category	Small-Cap
Price	$5.31
Price currency	USD
Rev Per Employee	140,939.5x
Sector	Healthcare
Sector PE	44.8
Sector PE Fwd	23.64
Sic	2834
Symbol	ABCL
Website	https://www.abcellera.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-8.88%
EV Sales Forward	40.4x
EV/Sales	15.87x
FCF yield	-11.67%
P/B ratio	1.72x
P/S ratio	20.47x
PS Forward	52.11x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-231.52%
EBITDA Margin	-192.55%
Gross margin	-141.13%
Gross Profit	$-111.8M
Net Income	$-144M
Net Income Growth Quarters	2%
Net Income Growth Years	1%
Pretax Margin	-219.86%
Profit Margin	-181.74%
Profit Per Employee	$-256,149
ROA	-9.99
Roa5y	-2.27
ROCE	-14.56
ROE	-14.68
Roe5y	-2.19
ROIC	-36.87
Roic5y	-12.85

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	6.42%
Cagr3y	-12.21%
Cagr5y	-19.59%
EPS Growth Quarters	2
EPS Growth Years	1
Revenue Growth	242.68x
Revenue Growth Q	96.34x
Revenue Growth Quarters	4x
Revenue Growth Years	1x
Revenue Growth3 Y	-24.08x
Revenue Growth5 Y	-28.75x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0.06
Assets	$1.3B
Cash	$504.7M
Current Assets	$664.6M
Current Liabilities	$47.3M
Debt	$140.2M
Debt Equity	$0.15
Equity	$938.1M
Liabilities	$369M
Long Term Assets	$642.5M
Long Term Liabilities	$321.7M
Net Cash	$364.6M
Net Cash By Market Cap	$22.48
Net Cash Growth	-32.17%
Net Debt Equity	$-0.39
Tangible Book Value	$852.8M
Tangible Book Value Per Share	$2.81
WACC	9.71

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	14.05
Net Working Capital	$118.4M
Quick ratio	12.29
Working Capital	$617.3M
Working Capital Turnover	$0.12

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-1.52%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	6.41%
200-day SMA	4.49
3Y total return	-32.36%
50-day SMA	5.96
50-day SMA vs 200-day SMA	50over200
5Y total return	-66.37%
All Time High	71.91
All Time High Change	-92.62%
All Time High Date	2020-12-11
All Time Low	1.89
All Time Low Change	180.8%
All Time Low Date	2025-04-07
ATR	0.55
Beta	1.15
Beta1y	2.64
Beta2y	1.75
Ch YTD	55.26
High	5.74
High52	8.44
High52 Date	2026-07-07
High52ch	-37.09%
Low	5.29
Low52	2.75
Low52 Date	2026-02-05
Low52ch	93.44%
Ma50ch	-10.88%
Premarket Change Percent	0.53
Premarket Price	$5.7
Premarket Volume	35,690
Price vs 200-day SMA	18.26%
RSI	38.22
RSI Monthly	50.73
RSI Weekly	52.82
Sharpe ratio	0.41x
Sortino ratio	0.71
Total Return	-1.52%
Tr YTD	55.26
Tr1m	-5.68%
Tr1w	-17.87%
Tr3m	31.11%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	9
Analyst Count Top	6
Analyst Price Target Top	$10.2
Analyst Ratings	Strong Buy
Analyst Ratings Top	Strong Buy
Earnings EPS Estimate	$-0.17
Earnings Revenue Estimate	7,798,400x
Earnings Revenue Estimate Growth	-54.35x
Operating Income	$-212M
Operating margin	-267.6
Price target	$10.5
Price Target Change	$97.74
Price Target Change Top	$92.09

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	205,088,547%
Float Percent	67.16%
Net Borrowing	30,953,000
Shares Insiders	22.93%
Shares Institutions	32.34%
Shares Out	305,375,393
Shares Qo Q	1.12%
Shares Yo Y	1.52%
Short Float	23.68%
Short Ratio	6.28
Short Shares	15.9

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-242.3M
Average Volume	6,750,912.8x
Bv Per Share	3.09
CAPEX	$-36M
Ch1m	-5.68
Ch1w	-17.87
Ch1y	6.41
Ch3m	31.11
Ch3y	-32.36
Ch5y	-66.37
Ch6m	25.24
Change	-6.35%
Change From Open	-6.35
Close	5.67
Days Gap	0
Depreciation Amortization	23,678,000
Dollar Volume	33,300,013.6
Earnings Date	2026-08-05
Earnings Time	amc
EBIT	$-183.4M
EBITDA	$-152.5M
EPS	$-0.48
F Score	3
FCF	$-189.2M
FCF EV Yield	-15.05x
FCF Per Share	$-0.62
Financing CF	15,304,000
Fiscal Year End	December
Founded	2,012
Goodwill	47,806,000
Income Tax	$-30.2M
Investing CF	54,734,000
Ipr	-73.45
Iprfo	-91.3
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-05-11
Last Report Date	2026-03-31
Last Split Type	Never
Last10k Filing Date	2026-02-24
Ma150	4.48
Ma150ch	18.61%
Ma20	6.85
Ma20ch	-22.44%
Net CF	-82,757,000
Next Earnings Date	2026-08-05
Open	5.67
Optionable	Yes
Position In Range	4.44
Post Close	5.31
Postmarket Change Percent	0.75
Postmarket Price	$5.35
Ppne	422,806,000
Pre Close	5.67
Price Date	2026-07-24
Ptbv Ratio	1.9
Relative Volume	0.93x
Revenue	79,208,000x
SBC By Revenue	66.94x
Share Based Comp	53,019,000
Tax By Revenue	-38.12x
Tr6m	25.24%
Volume	6,271,189
Z Score	1.84

AbCellera Biologics Inc. (ABCL)

Coverage state: Market snapshot only — no published research

Generate the first ABCL analysis

Price

Financial snapshot

Fair-value bridge

Analyst consensus

Latest news · ABCL

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All ABCL indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Analyst estimates

Ownership and float

Other indicators

Deeper analysis on ABCL

Frequently asked questions